FDA authorizes more devices so far in 2026, but it’s taking longer

FDA authorizes more devices so far in 2026, but it’s taking longer is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-07-01

Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.

Source: MedTech Dive